Understanding Variability in Behavioral Weight Loss Treatment Response in Young Women (Ready SET Health)

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04875091
Collaborator
(none)
45
1
1
13.1
3.4

Study Details

Study Description

Brief Summary

This study is a single-arm behavioral weight loss intervention for emerging adult women with in-person assessments at 0 (baseline) and 4 months (post-treatment) in addition to EMA data collection regarding risk factors known to interfere with program engagement and weight loss in this high-risk population (e.g., sleep, psychological distress, life events).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Ready SET Health
N/A

Detailed Description

This study will implement a 4-month Internet-based behavioral weight loss intervention in order to collect ecological momentary assessment (EMA) data that will shed light on real-time barriers to weight management. The intervention is evidence-based and adapted with respect to content and delivery mode in order to meet the needs of emerging adult women. Consenting and eligible participants will receive 1 virtual group session led by a trained interventionist followed by weekly emails directing them to an intervention website housing video and .pdf content, weekly text messages, emailed tailored feedback regarding their weight loss behaviors and progress, and a closed Facebook group to facilitate social support. All participants will be followed for 4 months with hybrid in-person/virtual assessments at 0 and 4 months; in addition, all participants will be asked to respond to EMA prompts throughout the 4-month intervention period (Week 2, Week 4, Week 7, and Week 13).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Understanding Drivers of Variability in Treatment Response Among Emerging Adults in Behavioral Obesity Treatment
Actual Study Start Date :
Jul 28, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Behavioral: Ready SET Health
This behavioral weight loss intervention will span 16 weeks. The first session (Week 1) will be a virtual "Weight Loss 101" group kick-off followed by 15 weeks of a technology-mediated program consisting of the following: weekly emailed content (videos and readings explaining key skills and strategies to produce weight loss) and weekly emailed tailored feedback (based on self-monitoring data from participants). A trained interventionist ("coach") will lead the group session, provide weekly tailored feedback, and monitor participant progress.

Outcome Measures

Primary Outcome Measures

  1. Weight change [4-months (post-intervention)]

    Percent weight change (fasting weight in kg, measured in-person by trained assessors)

Secondary Outcome Measures

  1. Weekly weight change [4-months (throughout intervention)]

    Weekly weight change (weight in lbs obtained through participants' Bluetooth-/wireless-connected study scale; converted to kg for analyses)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-25 years of age

  • BMI (body mass index) 25-45 kg/m2

  • Female gender identity

Exclusion Criteria:
  • Report of uncontrolled medical condition that may pose a safety issue given the recommendations for the diet and unsupervised physical activity

  • Diagnosed cardiovascular or metabolic disease

  • Report of a heart condition, chest pain during periods of activity or rest, or loss of consciousness

  • Recent change in use of medications that may impact weight or metabolic function

  • Cancer in the past 5 years, except non-melanoma skin cancers or early-stage cervical cancer

  • Current symptoms of alcohol or other substance dependence

  • Report of diagnosis or history of Anorexia Nervosa or Bulimia Nervosa, or any compensatory behaviors within the previous 3 months

  • Hospitalization for depression or other psychiatric disorder within the past 12 months

  • Lifetime history of bipolar disorder or psychotic disorder

  • Planning to move from the area within the study period

  • Currently pregnant, pregnant within the past 6 months, currently breastfeeding or planning to become pregnant within the next 6 months

  • Current involvement in a weight loss program or current use of weight loss medication

  • Recent significant weight loss

  • Inability to read or speak English

  • Lack of a smartphone or unwillingness to use it for study components

Contacts and Locations

Locations

Site City State Country Postal Code
1 Virginia Commonwealth University Richmond Virginia United States 23298

Sponsors and Collaborators

  • Virginia Commonwealth University

Investigators

  • Principal Investigator: Jessica G LaRose, PhD, Virginia Commonwealth University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT04875091
Other Study ID Numbers:
  • HM20018520
First Posted:
May 6, 2021
Last Update Posted:
Aug 17, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Virginia Commonwealth University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 17, 2022